FDA Approves METFORMIN HYDROCHLORIDE — ScieGen Pharmaceuticals, Inc.
ScieGen Pharmaceuticals, Inc. secured approval for generic Metformin HCl Extended-Release Tablets, addressing a significant portion of the massive Type 2 diabetes market with the filing likely to trigger mounting generic competition that drives down market prices.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed